The discovery of CDKN1B as a significantly mutated gene in small-intestinal NETs enhances understanding of tumor development and progression. This finding opens new avenues for targeted therapies and precision medicine.

Home » The discovery of CDKN1B as a significantly mutated gene in small-intestinal NETs enhances understanding of tumor development and progression. This finding opens new avenues for targeted therapies and precision medicine.